Swiss Tablets
Login
Mometasone 50 mcg 140 spray
Mometasone 50 mcg 140 spray

Mometasone 50 mcg 140 spray

Mometason-Mepha Nasenspray 50 mcg 140 Dos

  • 42.36 CHF

  • Price in reward points: 3131
In stock
Safe payments
Amount in a pack. 1 Dos
Storage temp. min 15 / max 25 ℃
QR Mometasone 50 mcg 140 spray

Description

Mometasone 50 mcg 140 spray is a topical corticosteroid formulated as a nasal spray designed to provide relief from nasal inflammation and related symptoms. Each spray delivers a measured dose of 50 micrograms of mometasone, a potent anti-inflammatory agent commonly used to manage conditions such as allergic rhinitis and nasal congestion.

This product contains 140 sprays, offering a convenient and long-lasting supply for regular use. The spray form allows for targeted application directly into the nasal passages, helping to reduce swelling, irritation, and discomfort associated with nasal allergies and other inflammatory nasal conditions.

Key features and benefits:

  • Delivers a precise dose of 50 mcg mometasone per spray
  • Helps alleviate nasal symptoms such as congestion, sneezing, and runny nose
  • Easy-to-use nasal spray format for direct application
  • Contains 140 sprays, suitable for extended treatment periods
  • Suitable for adults and children as directed by a healthcare professional

For optimal results, it is important to follow the recommended dosage and usage instructions provided by a healthcare provider or included with the product packaging. This nasal spray is intended for intranasal use only and should be used consistently as part of a treatment plan to manage nasal inflammation effectively.

Reviews (0)

Recently Viewed

SWISS TABLETS online consultation

Free consultation with an experienced pharmacist

Describe the symptoms or the right drug - we will help you choose its dosage or analogue, place an order with home delivery or just consult.
We are 14 pharmacists and 0 bots. We will always be in touch with you and will be able to communicate at any time.

Free
expert advice